Myomectomy Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Myomectomy Market size was around USD 903.04 Million in 2026 and is slated to grow at 9.12% CAGR from 2027 to 2036, attaining USD 2.16 Billion by 2036. The industry revenue for 2027 is assessed at USD 972.94 Million.
Get more details on this report
Request Free Sample ReportMyomectomy Market Intelligence Snapshot
Regional Market Dynamics
- North America led through well-developed healthcare infrastructure, broad gynecological care access, established surgical capabilities, and adoption of minimally invasive uterus-preserving procedures.
- Asia Pacific is growing fastest as women's healthcare access, hospital infrastructure, specialized gynecological services, and awareness of fertility-preserving minimally invasive procedures expand.
Segment Momentum
- Abdominal myomectomy accounted for 41.04% of the market in 2026 because it remains the preferred procedure for treating multiple or large uterine fibroids requiring direct surgical access and proven clinical effectiveness.
- Ambulatory surgical centers are expanding rapidly as more suitable procedures shift to outpatient care, offering shorter stays, streamlined treatment pathways, and greater convenience for eligible minimally invasive myomectomy patients.
Market Expansion Drivers
- Growing prevalence of uterine fibroids increasing demand for surgical treatment procedures
- Rising adoption of minimally invasive surgical techniques improving patient outcomes and recovery time
- Improved healthcare infrastructure in developing regions expanding access to gynecological surgeries
Leading Market Participants
- Leading companies in the myomectomy market include Medtronic plc (Ireland), Stryker Corporation (United States), Intuitive Surgical, Inc. (United States), Karl Storz SE & Co. KG (Germany), Hologic, Inc. (United States), B. Braun Melsungen AG (Germany), CooperSurgical, Inc. (United States), CONMED Corporation (United States), Minerva Surgical, Inc. (United States), Olympus Corporation (Japan)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 903.04 Million
- 2027 Estimated Market Size: USD 972.94 Million
- Projected Market Size: USD 2.16 Billion by 2036
- Growth Forecast: 9.12% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Abdominal Myomectomy (Type) | Hospitals & Clinics (End-use) | Laparoscopic Sealer (Product)
- Emerging Opportunity Segment: Laparoscopic Myomectomy (Type) | Ambulatory Surgical Centers (End-use) | Harmonic Scalpel (Product)
Market Growth Drivers and Industry Trends
Growing prevalence of uterine fibroids increasing demand for surgical treatment procedures
The increasing occurrence of uterine fibroids among women of reproductive age is creating sustained demand for effective treatment options, which will drive the myomectomy market growth across healthcare systems. As fibroids become associated with symptoms such as heavy menstrual bleeding, pelvic pain, and fertility complications, more patients seek surgical intervention when conservative treatments prove insufficient. Myomectomy remains a preferred uterus-preserving procedure for women who wish to maintain reproductive potential, encouraging healthcare providers to expand access to specialized gynecological surgical services.
Rising adoption of minimally invasive surgical techniques improving patient outcomes and recovery time
Advances in laparoscopic and robotic-assisted procedures are transforming gynecological surgery by reducing procedural trauma while improving clinical outcomes, strengthening the myomectomy market. Minimally invasive techniques enable surgeons to perform fibroid removal with smaller incisions, lower blood loss, and reduced postoperative discomfort compared with conventional open surgery. Shorter hospital stays, faster recovery, and quicker return to normal activities also contribute to greater patient acceptance and broader utilization of these advanced surgical approaches.
Improved healthcare infrastructure in developing regions expanding access to gynecological surgeries
Ongoing investments in healthcare facilities, surgical capabilities, and specialist training are improving the availability of advanced women's healthcare services, benefiting the myomectomy market. Developing regions are expanding hospital capacity and equipping medical centers with modern surgical technologies that support complex gynecological procedures. Greater accessibility to skilled healthcare professionals, improved diagnostic services, and enhanced referral networks enable more patients to receive timely surgical management for uterine fibroids.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing prevalence of uterine fibroids increasing demand for surgical treatment procedures | 2.3% | High | North America, Europe, Asia Pacific | High | Near Term |
| Rising adoption of minimally invasive surgical techniques improving patient outcomes and recovery time | 2.1% | High | North America, Europe | High | Near Term |
| Improved healthcare infrastructure in developing regions expanding access to gynecological surgeries | 1.8% | High | Asia Pacific, Latin America | High | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The myomectomy market was led by North America in 2026, supported by well-developed healthcare infrastructure, broad access to gynecological care, and increasing awareness of uterus-preserving treatment options for uterine fibroids. The region's established surgical capabilities and availability of advanced minimally invasive procedures are encouraging patients and healthcare providers to consider myomectomy as an effective treatment option. Greater emphasis on preserving fertility and reducing recovery time is also supporting the adoption of laparoscopic and other less invasive surgical approaches.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region for the myomectomy market, supported by improving access to women's healthcare and increasing recognition of uterine fibroids as a condition requiring timely intervention. Expanding hospital infrastructure, greater availability of specialized gynecological services, and growing healthcare expenditure are improving access to surgical treatment. In addition, rising awareness of fertility-preserving procedures and increasing adoption of minimally invasive techniques are encouraging more patients to seek myomectomy, particularly in developing healthcare markets across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Minimally Invasive ProceduresThe U.S. myomectomy market is expanding the use of minimally invasive surgical techniques that shorten recovery times while preserving fertility. Healthcare providers are investing in advanced surgical technologies and specialized gynecologic care to improve treatment outcomes.
Germany 🇩🇪
Clinical Procedure OptimizationGermany's myomectomy market emphasizes standardized surgical protocols and advanced imaging to improve procedural planning. Hospitals are refining minimally invasive approaches that enhance surgical precision while supporting individualized patient care.
Japan 🇯🇵
Fertility Preservation PriorityJapan's myomectomy market places significant emphasis on fertility-preserving treatment options for women diagnosed with uterine fibroids. Medical centers are strengthening minimally invasive surgical capabilities to improve recovery and reproductive health management.
South Korea 🇰🇷
Advanced Gynecologic SurgerySouth Korea is expanding access to technologically advanced gynecologic procedures through robotic and laparoscopic surgical platforms. The myomectomy market reflects growing demand for precise interventions that minimize hospital stays and postoperative complications.
France 🇫🇷
Patient-Centered Treatment PlanningFrance's myomectomy market focuses on individualized treatment selection based on patient health, reproductive goals, and fibroid characteristics. Healthcare providers continue integrating minimally invasive techniques into routine gynecologic surgical practice.
Italy 🇮🇹
Specialized Women's HealthcareItaly's myomectomy market benefits from increasing adoption of specialized gynecologic services focused on effective fibroid management. Hospitals are enhancing surgical expertise and procedural efficiency to support improved patient recovery and long-term reproductive health.
Myomectomy Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Abdominal Myomectomy (Largest Segment) vs Laparoscopic Myomectomy (Fastest-Growing Segment)
Holding the largest share of the myomectomy market, the abdominal myomectomy segment accounted for 41.04% in 2026. The procedure continues to be widely adopted for treating patients with multiple or large uterine fibroids that require direct surgical access. Its established clinical effectiveness and suitability for complex cases make it a preferred treatment option in many healthcare settings, particularly when minimally invasive techniques are not appropriate.
Laparoscopic myomectomy is expected to experience the fastest growth as both patients and healthcare providers increasingly favor minimally invasive procedures. Smaller incisions, reduced postoperative discomfort, shorter recovery periods, and improved cosmetic outcomes are encouraging greater adoption of laparoscopic techniques, supported by ongoing advances in surgical technology and physician expertise.
End-use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals & clinics captured 44.52% of the market share in 2026, making them the leading end-use segment. These facilities offer comprehensive gynecological care, experienced surgical teams, advanced operating infrastructure, and the capability to manage both routine and complex myomectomy procedures. Their integrated diagnostic, surgical, and postoperative care services continue to support their dominant position in the market.
In the myomectomy market, ambulatory surgical centers are anticipated to register the fastest growth as healthcare systems increasingly shift suitable procedures toward outpatient settings. These centers provide efficient surgical care with shorter patient stays, streamlined treatment pathways, and enhanced convenience, making them an increasingly attractive option for eligible minimally invasive myomectomy procedures.
Product Segment Analysis: Laparoscopic Sealer (Largest Segment) vs Harmonic Scalpel (Fastest-Growing Segment)
Laparoscopic sealers represented the largest product segment in 2026, owing to their ability to provide reliable vessel sealing and effective bleeding control during minimally invasive gynecological procedures. Their contribution to procedural efficiency, improved surgical precision, and enhanced patient safety has made them a widely utilized instrument in modern myomectomy surgeries.
The harmonic scalpel segment is expected to grow the fastest as surgeons increasingly adopt advanced energy-based devices that enable precise tissue dissection while minimizing thermal damage to surrounding structures. Continuous technological improvements and growing demand for minimally invasive surgical instruments are expected to strengthen the adoption of harmonic scalpels in myomectomy procedures.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy | Abdominal Myomectomy | Laparoscopic Myomectomy |
| End-use | Hospitals & Clinics, Ambulatory Surgical Centers, Others | Hospitals & Clinics | Ambulatory Surgical Centers |
| Product | Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Others | Laparoscopic Sealer | Harmonic Scalpel |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the myomectomy market:
- Medtronic plc (Ireland)
- Stryker Corporation (United States)
- Intuitive Surgical, Inc. (United States)
- Karl Storz SE & Co. KG (Germany)
- Hologic, Inc. (United States)
- B. Braun Melsungen AG (Germany)
- CooperSurgical, Inc. (United States)
- CONMED Corporation (United States)
- Minerva Surgical, Inc. (United States)
- Olympus Corporation (Japan)
Clinical practice is steadily favoring treatment approaches that preserve reproductive potential while reducing procedural burden, encouraging competition around minimally invasive surgical capabilities and improved patient outcomes. Healthcare providers increasingly evaluate surgical solutions based on procedural precision, recovery experience, and compatibility with advanced imaging and operative technologies rather than relying solely on traditional techniques. Competitive positioning is also being shaped by expanding surgical expertise, greater emphasis on individualized treatment planning, and technologies that help improve procedural consistency across different healthcare settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Stryker Corporation (United States) | |||||||
| Intuitive Surgical Inc. (United States) | |||||||
| Karl Storz SE & Co. KG (Germany) | |||||||
| Hologic Inc. (United States) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| CooperSurgical Inc. (United States) | |||||||
| CONMED Corporation (United States) | |||||||
| Minerva Surgical Inc. (United States) | |||||||
| Olympus Corporation (Japan) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Intuitive Surgical | Apr-25 | The U.S. FDA cleared the da Vinci 5 robotic platform, incorporating advanced engineering enhancements designed to improve precision and outcomes in minimally invasive surgical procedures, including gynecologic interventions. |
| Hologic | Jan-25 | Hologic completed a USD 350 million acquisition of Gynesonics, successfully integrating the incision-free Sonata System into its surgical product portfolio for fibroid and uterine treatments. |
| Boston Scientific | Mar-24 | Boston Scientific launched upgraded carbon dioxide lasers tailored for gynecology, expanding specialized procedural options available to clinicians for targeted fibroid resection and removal. |
| Hologic, Inc. | Oct-21 | Hologic acquired Bolder Surgical, a privately held developer of advanced energy vessel sealing surgical devices, expanding its specialized surgical portfolio and strengthening its competitive market position. |
| Hologic Inc. | Aug-20 | Hologic acquired Acessa Health Inc., a specialist in minimally invasive fibroid therapies, directly strengthening its product portfolio and capabilities for advanced uterine fibroid treatment options. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Myomectomy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Under 30 Years, 30–39 Years, 40–49 Years, 50 Years and Above |
| Fibroid Location | Submucosal Fibroids, Intramural Fibroids, Subserosal Fibroids, Cervical and Other Fibroids |
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay |
Myomectomy Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Patient Treatment Pathway Analysis |
|
| Procedure Adoption & Access Gaps |
|
| Surgeon Preference & Procedure Selection |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of myomectomy?
How much is the myomectomy industry expected to grow by 2036?
Why is minimally invasive surgery accelerating growth in the myomectomy market?
How is healthcare infrastructure expansion supporting the myomectomy market?
Why does abdominal myomectomy hold the largest share of the myomectomy market?
Why are ambulatory surgical centers the fastest-growing end-use segment in the myomectomy market?
Why did North America lead the myomectomy market in 2026?
How is Asia Pacific accelerating myomectomy market growth?
Which companies dominate the myomectomy landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook